Back
CVS Health Quote, Financials, Valuation and Earnings
Sponsored
New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register Here
Sell
33
CVS
CVS Health
Last Price:
87.90
Seasonality Move:
7.64%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!CVS Health Price Quote
$87.90
+0.12 (+0.14%)
(Updated: January 30, 2023 at 12:10 PM ET)
CVS Health Key Stats
Sell
33
CVS Health (CVS)
is a Sell
Day range:
$87.00 - $88.12
52-week range:
$84.82 - $111.25
Dividend yield:
2.57%
P/E ratio:
14.75
P/S ratio:
0.37
P/B ratio:
1.63%
Volume:
7.4M
Avg. volume:
8.7M
1-year change:
-17.8%
Market cap:
$115.3B
Revenue:
$292.1B
EPS:
$2.35
How Much Does CVS Health Make?
-
How Much Are CVS Health's Sales Annually?
CVS Revenues are $292.1B -
How Much Profit Does CVS Health's Make A Year?
CVS net income is $7.9B
Is CVS Health Growing As A Company?
-
What Is CVS Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is CVS Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
CVS Health Stock Price Performance
-
Did CVS Health Stock Go Up Last Month?
CVS Health share price went down by -5.63% last month -
Did CVS's Share Price Rise Over The Last Year?
CVS share price fell by -17.8% over the past 1 year
What Is CVS Health 52-Week High & Low?
-
What Is CVS Health’s 52-Week High Share Price?
CVS Health has traded as high as $111.25 over the past 52 weeks -
What Is CVS Health’s 52-Week Low Share Price?
CVS Health has traded as low as $84.82 over the past 52 weeks
CVS Health Price To Free Cash Flow
-
Is CVS Health Stock Overvalued?
CVS Health is trading at a price to free cash flow ratio of 5.97 -
Is CVS Health Stock Undervalued?
CVS Health EV to Free Cash Flow ratio is 7.58 -
What Is CVS Health’s Price Earnings Growth Ratio?
CVS PEG ratio is 0.00 -
Is CVS Health Trading At A Premium To Earnings?
CVS Health EV to EBIT ratio is 22.99
Is It Risky To Buy CVS Health?
-
How Much Debt Does CVS Health Have?
Total long term debt quarterly is $52.2B -
How Much Cash Does CVS Health Have?
Cash and short term investments quarterly total is $20B -
What Is CVS Health’s Book Value Per Share?
Book value per share is 53.75
Is CVS Health Cash Flow Positive?
-
What Is CVS Cash Flow From Operations?
Cash flow from operations (TTM) is $22.1B -
What Is CVS Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$11.2B -
What Is CVS Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.4B
CVS Health Return On Invested Capital
-
Is Management Doing A Good Job?
CVS return on invested capital is 2.43% -
What Is CVS Health Return On Assets?
ROA measures how assets are converting to revenues and is 1.36% -
What Is CVS Return On Equity?
ROE is a measure of profitability and is 4.27%
CVS Health Earnings Date & Stock Price
-
What Is CVS Health's Stock Price Today?
A single share of CVS can be purchased today for 87.78 -
What Is CVS Health’s Stock Symbol?
CVS Health trades on the S&P500 under the ticker symbol: CVS -
When Is CVS Health’s Next Earnings Date?
The next quarterly earnings date for CVS Health is scheduled on February 8, 2023 -
When Is CVS's next ex-dividend date?
CVS Health's next ex-dividend date is January 19, 2023 -
How To Buy CVS Health Stock?
You can buy CVS Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CVS Health Competitors
-
Who Are CVS Health's Competitors?
Below is a list of companies who compete with CVS Health or are related in some way:
CVS Health Dividend Yield
-
What Is CVS Dividend Yield?
CVS Health’s dividend yield currently is 2.57% -
What Is CVS Health’s Payout Ratio?
CVS Health’s payout ratio is 90.33% -
When Did CVS Health Last Pay A Dividend?
The latest dividend pay date is January 30, 2023 -
What Is CVS Health’s Dividend Per Share?
CVS Health pays a dividend of $0.55 per share
CVS Health Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 7.94% |
| Revenue: | 9.98% | 5.7% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 8 |
| Sell Recommendations: | 0 |
| Price Target: | 115.86 |
| Upside from Last Price: | 31.99% |